Trade ACET stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Adicet Bio, Inc. (ACET) is trading at US$2.99, down 0.33% today as of Nov 11, 16:00 EST. The company has a market capitalisation of US$86.03M. Over the past 52 weeks, ACET has traded between US$2.86 and US$11.20. On Syfe you can trade ACET with $0 commission and add it to your watchlist.
| Previous close | US$3.00 |
|---|---|
| Market cap | US$86.03M |
| 52-week range | US$2.86 – US$11.20 |
| Volume | 416.46K |
| Exchange | US |
Adicet Bio, Inc.
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Year: 2020
--Wedbush Adjults Adicet Bio Price Target to $28 From $25, Maintains Outperform Rating
Sep 28, 2:09 PM · MT Newswires
Adicet Bio Gets FDA Clearance for IND for ADI-212 in prostate cancer
Aug 27, 9:00 PM · MT Newswires
Adicet Bio, Inc. (ACET) stock is trading at US$2.99, -0.33% from the previous close of US$3.00.
The market cap for Adicet Bio, Inc. (ACET) stock is approximately US$86.03M.
The 52-week high for Adicet Bio, Inc. (ACET) stock is US$11.20.
The 52-week low for Adicet Bio, Inc. (ACET) stock is US$2.86.
Adicet Bio, Inc. (ACET) does not currently pay a dividend.
Stay on top of ACET
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
